Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313485061> ?p ?o ?g. }
- W4313485061 abstract "Abstract Background Abnormalities of FGFR1 have been reported in multiple malignancies, which proposes FGFR1 as a potential target for precision treatment, whereas drug resistance remains a formidable obstacle simultaneously. Methods RNA-seq analysis, mouse tumor models, and flow cytometry were performed to identify that the FGFR1 was a potential target in T-ALL. RNA-seq, ATAC-seq, targeted metabolomics analysis, surface sensing of translation (SUnSET) assay, western blot assays, and qRT-PCR were used to investigate the underlying mechanisms of FGFR1-targeting resistance. Drug screening was conducted to identify a drug combination strategy for overcoming this drug resistance. Results We identified that FGFR1 was observably upregulated in T-ALL and inversely correlated with the prognosis of patients. Functional studies showed that the knockdown of FGFR1 suppressed T-ALL cells growth and progression both in vitro and in vivo . Whereas the human T-ALL cells were resistant to FGFR1 inhibitors. Mechanistically, we identified that ATF4 was markedly upregulated and was a major initiator for T-ALL resistance to FGFR1 inhibitors. Expression of ATF4 was induced by FGFR1 inhibitors through enhancing chromatin accessibility transcriptionally combined with activating translation via the GCN2-eIF2α pathway. Then, ATF4 remodeled the amino acid metabolism by stimulating the expression of multiple metabolic genes, and further maintained the activation of mTORC1, which contributed to the drug resistance of malignancies. Moreover, targeting FGFR1 and mTOR exhibited synergistically antileukemic efficacy. Conclusion These findings revealed that FGFR1 was a potential therapeutic target in T-ALL, whereas ATF4-induced amino acid metabolic reprogramming mediated the FGFR1-targeted resistance. Synergistically targeting FGFR1 and mTOR could overcome this obstacle in T-ALL therapy." @default.
- W4313485061 created "2023-01-06" @default.
- W4313485061 creator A5000216561 @default.
- W4313485061 creator A5011320222 @default.
- W4313485061 creator A5011571848 @default.
- W4313485061 creator A5012230483 @default.
- W4313485061 creator A5012988764 @default.
- W4313485061 creator A5016614811 @default.
- W4313485061 creator A5018073672 @default.
- W4313485061 creator A5022163147 @default.
- W4313485061 creator A5031589458 @default.
- W4313485061 creator A5035291122 @default.
- W4313485061 creator A5036367651 @default.
- W4313485061 creator A5037659439 @default.
- W4313485061 creator A5040643591 @default.
- W4313485061 creator A5044756037 @default.
- W4313485061 creator A5050266562 @default.
- W4313485061 creator A5054925082 @default.
- W4313485061 creator A5056139025 @default.
- W4313485061 creator A5063880073 @default.
- W4313485061 creator A5064491433 @default.
- W4313485061 creator A5068290128 @default.
- W4313485061 creator A5083558289 @default.
- W4313485061 creator A5088875336 @default.
- W4313485061 creator A5088998848 @default.
- W4313485061 creator A5091147451 @default.
- W4313485061 date "2023-01-04" @default.
- W4313485061 modified "2023-09-27" @default.
- W4313485061 title "ATF4 drives the resistance of T-ALL against FGFR1 inhibitors through amino acid metabolic reprogramming" @default.
- W4313485061 cites W1894751757 @default.
- W4313485061 cites W1966921801 @default.
- W4313485061 cites W1988476050 @default.
- W4313485061 cites W1990147363 @default.
- W4313485061 cites W2032189193 @default.
- W4313485061 cites W2035297454 @default.
- W4313485061 cites W2056983875 @default.
- W4313485061 cites W2079838847 @default.
- W4313485061 cites W2097289227 @default.
- W4313485061 cites W2108285390 @default.
- W4313485061 cites W2118155696 @default.
- W4313485061 cites W2145393147 @default.
- W4313485061 cites W2147413677 @default.
- W4313485061 cites W2153089464 @default.
- W4313485061 cites W2155557355 @default.
- W4313485061 cites W2170551349 @default.
- W4313485061 cites W2179438025 @default.
- W4313485061 cites W2518959324 @default.
- W4313485061 cites W2541714644 @default.
- W4313485061 cites W2550856922 @default.
- W4313485061 cites W2595713273 @default.
- W4313485061 cites W2741309469 @default.
- W4313485061 cites W2742971656 @default.
- W4313485061 cites W2888141473 @default.
- W4313485061 cites W2945883683 @default.
- W4313485061 cites W2964315448 @default.
- W4313485061 cites W3000183179 @default.
- W4313485061 cites W3002071299 @default.
- W4313485061 cites W3094173567 @default.
- W4313485061 cites W3108059695 @default.
- W4313485061 cites W3126463532 @default.
- W4313485061 cites W3142100769 @default.
- W4313485061 cites W3143216650 @default.
- W4313485061 cites W3186228217 @default.
- W4313485061 cites W3187888740 @default.
- W4313485061 cites W3204825756 @default.
- W4313485061 cites W4226037460 @default.
- W4313485061 cites W4283265889 @default.
- W4313485061 cites W4286511467 @default.
- W4313485061 doi "https://doi.org/10.21203/rs.3.rs-2415441/v1" @default.
- W4313485061 hasPublicationYear "2023" @default.
- W4313485061 type Work @default.
- W4313485061 citedByCount "0" @default.
- W4313485061 crossrefType "posted-content" @default.
- W4313485061 hasAuthorship W4313485061A5000216561 @default.
- W4313485061 hasAuthorship W4313485061A5011320222 @default.
- W4313485061 hasAuthorship W4313485061A5011571848 @default.
- W4313485061 hasAuthorship W4313485061A5012230483 @default.
- W4313485061 hasAuthorship W4313485061A5012988764 @default.
- W4313485061 hasAuthorship W4313485061A5016614811 @default.
- W4313485061 hasAuthorship W4313485061A5018073672 @default.
- W4313485061 hasAuthorship W4313485061A5022163147 @default.
- W4313485061 hasAuthorship W4313485061A5031589458 @default.
- W4313485061 hasAuthorship W4313485061A5035291122 @default.
- W4313485061 hasAuthorship W4313485061A5036367651 @default.
- W4313485061 hasAuthorship W4313485061A5037659439 @default.
- W4313485061 hasAuthorship W4313485061A5040643591 @default.
- W4313485061 hasAuthorship W4313485061A5044756037 @default.
- W4313485061 hasAuthorship W4313485061A5050266562 @default.
- W4313485061 hasAuthorship W4313485061A5054925082 @default.
- W4313485061 hasAuthorship W4313485061A5056139025 @default.
- W4313485061 hasAuthorship W4313485061A5063880073 @default.
- W4313485061 hasAuthorship W4313485061A5064491433 @default.
- W4313485061 hasAuthorship W4313485061A5068290128 @default.
- W4313485061 hasAuthorship W4313485061A5083558289 @default.
- W4313485061 hasAuthorship W4313485061A5088875336 @default.
- W4313485061 hasAuthorship W4313485061A5088998848 @default.
- W4313485061 hasAuthorship W4313485061A5091147451 @default.
- W4313485061 hasBestOaLocation W43134850611 @default.
- W4313485061 hasConcept C104317684 @default.
- W4313485061 hasConcept C127561419 @default.